This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

CDR Michael O'Leary, USN, MC
San Diego, Calif

Arch Otolaryngol Head Neck Surg. 1994;120(2):240.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The fall program of the American Neurotology Society was held in Minneapolis, Minn, on October 1, 1993.

The number of clinical applications for otoacoustic emissions testing has grown exponentially since Kemp's 1978 report, according to neurophysiologist Brenda Lonsbury-Martin, PhD. The emissions are sounds generated by the cochlea and are classified as spontaneous or evoked, the latter in response to a test stimulus such as a click or a tone. Advantages include the brevity, objectivity, and reliability of this simple, noninvasive test. Current areas of use of otoacoustic emissions testing include neonatal screening, serial testing in Meniere's disease, and assessment of hearing loss in the range of 2000 to 4000 Hz, which may present a problem for auditory brain-stem–evoked responses. Possible use in combination with other auditory test batteries, including electrocochleography and intraoperative monitoring, offer exciting prospects for otoacoustic emissions testing in the near future.

An investment of research energy . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?